Literature DB >> 23390946

Pulmonary manifestations of chronic granulomatous disease.

Seyed Alireza Mahdaviani1, Seyed Amir Mohajerani, Nima Rezaei, Jean-Laurent Casanova, Seyed Davood Mansouri, Ali Akbar Velayati.   

Abstract

Chronic granulomatous disease (CGD) is an inherited disorder, characterized by defects in superoxide-generating NADPH oxidase of phagocytes. The genetic defects in CGD induce failure to activate the respiratory burst in the phagocytes, leading to severe recurrent infections and unexplained prolonged inflammatory reactions that may produce granulomatous lesions. A noble advance in curative therapy for CGD is hematopoietic stem cell transplantation. Since the most common site of involvement in CGD is the lung, the pulmonologists (pediatrics or adult) may be among the first to recognize the pattern of infection, inflammation and granuloma formation, leading to diagnosis of CGD. Pulmonologists need to be aware of different lung manifestations of CGD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23390946     DOI: 10.1586/eci.12.98

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  22 in total

1.  ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine.

Authors:  Gaëtane C Michaud; Colleen L Channick; Chad R Marion; Robert M Tighe; James A Town; Andrew M Luks; Jeremy B Richards; Sucharita Kher; Prerna Mota; Gina Hong; Natalie E West; Craig Rackley; Luke Neilans; Josanna Rodriguez-Lopez; Hilary DuBrock; Cassie C Kennedy; Diana J Kelm; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2015-09

2.  A 60-year-old asymptomatic woman with pulmonary lesions and cervical lymphadenopathy.

Authors:  Tomoko Yamagishi; Nobuaki Ochi; Hiromichi Yamane; Futoshi Kuribayashi; Nagio Takigawa
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

Review 3.  Infectious Complications in Patients With Chronic Granulomatous Disease.

Authors:  Nicholas Bennett; Paul J Maglione; Benjamin L Wright; Christa Zerbe
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

4.  Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry.

Authors:  Meera Patrawala; Ying Cui; Limin Peng; Ramsay L Fuleihan; Elizabeth K Garabedian; Kiran Patel; Lokesh Guglani
Journal:  J Clin Immunol       Date:  2020-01-09       Impact factor: 8.317

5.  Early Identification of Lung Fungal Infections in Chronic Granulomatous Disease (CGD) Using Multidetector Computer Tomography.

Authors:  Maria Pia Bondioni; Vassilios Lougaris; Giuseppe Di Gaetano; Tiziana Lorenzini; Annarosa Soresina; Francesco Laffranchi; Diego Gatta; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2016-10-21       Impact factor: 8.317

6.  Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD.

Authors:  Saliha Esenboga; Nagehan Emiralioglu; Deniz Cagdas; Baran Erman; Martin De Boer; Berna Oguz; Nural Kiper; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2017-02-21       Impact factor: 8.317

7.  Clinical and molecular features of 38 children with chronic granulomatous disease in mainland china.

Authors:  Huan Xu; Wen Tian; Shu-Juan Li; Lu-Ying Zhang; Wei Liu; Yao Zhao; Zhi-Yong Zhang; Xue-Mei Tang; Mo Wang; Dao-Qi Wu; Ji-Sheng Shi; Yuan Ding; Xiao-Dong Zhao; Xi-Qiang Yang; Li-Ping Jiang
Journal:  J Clin Immunol       Date:  2014-06-19       Impact factor: 8.317

8.  Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience.

Authors:  Halil Tuna Akar; Saliha Esenboga; Deniz Cagdas; Sevil Oskay Halacli; Begum Ozbek; Karin van Leeuwen; Martin de Boer; Cagman Sun Tan; Yavuz Köker; Dirk Roos; Ilhan Tezcan
Journal:  J Clin Immunol       Date:  2021-02-24       Impact factor: 8.317

9.  Macrophage-specific NOX2 contributes to the development of lung emphysema through modulation of SIRT1/MMP-9 pathways.

Authors:  Candice Trocme; Christine Deffert; Julien Cachat; Yves Donati; Christelle Tissot; Sylvie Papacatzis; Vincent Braunersreuther; Jean-Claude Pache; Karl-Heinz Krause; Rikard Holmdahl; Constance Barazzone-Argiroffo; Stéphanie Carnesecchi
Journal:  J Pathol       Date:  2014-11-06       Impact factor: 7.996

10.  Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.

Authors:  Alessandra Magnani; Nizar Mahlaoui
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.